PTPRC and neoplasm: The proportion of CD45+ immune cells in tumor tissues was significantly increased following B002T‐LP004 administration compared to the other groups, indicating the upregulation of myeloid cells with inherent natural immunity and increased immune infiltration in tumor tissues (Figure 5B).